Rincon Bio performs MIAPaCa-2 xenograft models to test efficacy of preclinical therapies. Please see below for additional information or to request a quote.
MIAPaCa-2 cells were derived from 65 year old male Caucasian
Organism: Homo sapiens, human / Cell Type: epithelial cell / Tissue: pancreas / Disease: carcinoma
Used in xenografts to test the efficacy of novel cancer therapeutics. Tumors develop after being injected into the flank of immunocompromised mice.
Rincon Bio Growth Curve
Cell Line: MIAPaCa-2
Mouse Strain: Athymic Nude from Harlan Laboratories
Positive Control: None
Cells Implanted per Animal: 5 million
From implant to stratification: 8 days
Stratification Size: 72mm^3
Dosing: Vehicle - N/A
WHY WORK WITH
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
Most efficacy studies can be initiated within two business days.
We love our clients! We are flexible and easy to work with. And we take a personal interest in our clients' studies.